3SBio Inc

ISIC Code: 

Listed on the Hong Kong Stock Exchange (HKEx) as 1530 (5 Jun 2015)
3SBio is a fully integrated, profitable biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products primarily in China. The company is manufacturing two leading products: EPIAO, a recombinant erythropoietin (rhEPO) injection for anemia in kidney disease and dialysis and anemia associated with chemotherapy and TPIAO, a recombinant human thrombopoietin (rhTPO) injection for chemotherapy induced thrombocytopenia.